Overview

Acute Pain Study Following Bunionectomy

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
0
Participant gender:
All
Summary
The primary purpose of this study was to evaluate analgesic efficacy and safety of hydrocodone/acetaminophen extended release compared to placebo in the treatment of moderate to severe pain following bunionectomy.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
AbbVie (prior sponsor, Abbott)
Treatments:
Acetaminophen
Acetaminophen, hydrocodone drug combination
Hydrocodone
Oxycodone
Criteria
Inclusion Criteria:

Subjects who were in general good health, experiencing moderate to severe pain following
bunionectomy

Exclusion Criteria:

- Subjects who underwent Base wedge osteotomy and / or Long-Z Hart bunionectomy
procedures

- Drug allergies to hydrocodone, acetaminophen

- Clinically significant or uncontrolled medical disorders or illness - history of drug
or alcohol abuse / addiction